Gilead Sciences Overview
Gilead Sciences Target Price
Analysts' 12-month price predictions for GILD.
Share Price
$92.13
Average Target Price
$87.18
5.4% downside
5.4% downside11 analysts in the last 4 months
High: $105 | Low: $71
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-11-07 | Piper SandlerJoseph Catanzaro | $105 |  14% upside |  |
| 2024-10-21 | BMO CapitalEvan David Seigerman | $94 | 2% upside | |
| 2024-10-21 | Leerink PartnersAndrew Berens | $96 | 4.2% upside | |
| 2024-10-18 | Morgan StanleyTerence Flynn | $84 | 8.8% downside | |
| 2024-09-23 | JefferiesMichael Yee | $95 | 3.1% upside | |
| 2024-09-12 | Morgan StanleyTerence Flynn | $79 | 14.3% downside | |
| 2024-09-12 | Goldman SachsSalveen Richter | $71 | 22.9% downside | |
| 2024-09-11 | Piper SandlerJoseph Catanzaro | $95 | 3.1% upside | |
| 2024-08-14 | Truist FinancialAsthika Goonewardene | $83 | 9.9% downside | |
| 2024-08-09 | BMO CapitalEvan David Seigerman | $85 | 7.7% downside | |
| 2024-08-09 | RBC CapitalBrian Abrahams | $72 | 21.8% downside | |
| 2024-07-08 | Raymond JamesSteven Seedhouse | $93 | 0.9% upside | |
| 2024-06-24 | JefferiesMichael Yee | $85 | 7.7% downside | |
| 2024-06-20 | Robert W. BairdBrian Skorney | $80 | 13.2% downside | |
| 2024-06-17 | Mizuho SecuritiesSalim Syed | $90 | 2.3% downside | |
| 2024-06-14 | RBC CapitalBrian Abrahams | $74 | 19.7% downside | |
| 2024-05-20 | BMO CapitalEvan David Seigerman | $80 | 13.2% downside | |
| 2024-04-24 | HSBCMorten Herholdt | $69 | 25.1% downside | |
| 2024-02-14 | RBC CapitalBrian Abrahams | $76 | 17.5% downside | |
| 2023-09-27 | RBC CapitalBrian Abrahams | $84 | 8.8% downside | |
| 2023-09-08 | Bank of America SecuritiesGeoff Meacham | $95 | 3.1% upside | |
| 2023-02-03 | Leerink Partners | $91 | 1.2% downside | |
| 2023-02-03 | Piper Sandler | $112 | 21.6% upside | |
| 2023-01-03 | Wells Fargo | $90 | 2.3% downside | |
| 2022-12-01 | Morgan Stanley | $81 | 12.1% downside | |
| 2022-10-31 | BarclaysCarter Gould | $76 | 17.5% downside | |
| 2022-10-28 | Truist FinancialRobyn Karnauskas | $91 | 1.2% downside | |
| 2022-10-28 | Robert W. BairdBrian Skorney | $69 | 25.1% downside | |
| 2022-09-15 | Truist Financial | $76 | 17.5% downside | |
| 2022-09-13 | Wells Fargo | $74 | 19.7% downside | |
| 2022-07-15 | Morgan Stanley | $65 | 29.4% downside | |
| 2022-05-23 | Leerink PartnersDavid Risinger | $68 | 26.2% downside | |
| 2022-05-17 | Piper SandlerDo Kim | $69 | 25.1% downside | |
| 2022-04-29 | BMO Capital | $63 | 31.6% downside | |
| 2022-04-29 | Piper Sandler | $73 | 20.8% downside | |
| 2022-04-06 | Piper SandlerDo Kim | $71 | 22.9% downside | |
| 2022-03-31 | Wells FargoMohit Bansal | $63 | 31.6% downside | |
| 2022-03-01 | JefferiesMichael Yee | $80 | 13.2% downside | |
| 2022-02-24 | Morgan StanleyMatthew Harrison | $69 | 25.1% downside | |
| 2022-02-24 | UBSColin Bristow | $54 | 41.4% downside | |
| 2022-02-08 | Mizuho SecuritiesSalim Syed | $75 | 18.6% downside | |
| 2022-02-04 | Atlantic EquitiesSteve Chesney | $62 | 32.7% downside | |
| 2022-02-03 | Maxim GroupJason McCarthy | $84 | 8.8% downside | |
| 2022-02-03 | OppenheimerHartaj Singh | $90 | 2.3% downside | |
| 2022-01-28 | Argus ResearchDavid Toung | $75 | 18.6% downside | |
| 2021-12-06 | Goldman SachsSalveen Richter | $80 | 13.2% downside | |
| 2021-11-19 | WedbushRobert Driscoll | $67 | 27.3% downside | |
| 2021-04-29 | J.P. MorganCory Kasimov | $74 | 19.7% downside | |